UK Medtechs Fear That Pre-COVID-19 Activity May Be Over A Year Away
Long Waiting Lists And Patients' Reluctance To Present For Cancer And Other Care Are Compounding An Already Difficult Situation
Executive Summary
Top of the agenda for the medtech industry globally is when the “new normal” will return. In the UK, the expectations are that post-COVID-19 health care activity will increase gradually, but it is possible that the National Health Service will not reach its pre-coronavirus capacities until late in 2021, “if at all.”